[Skip to Content]
[Skip to Content Landing]
Article
October 1984

News and Notes

Arch Dermatol. 1984;120(10):1286. doi:10.1001/archderm.1984.01650460026013

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

HYTONE® (hydrocortisone) Lotion, Cream, Ointment 2½% and 1% Brief Summary Indications: To relieve inflammatory manifestations of corticosteroid-responsive dermatoses. Contraindications: History of hypersensitivity to any component. Precautions: If irritation develops, discontinue use and institute appropriate therapy. Use appropriate antifungal or antibacterial agent for infection; if favorable response does not occur promptly, discontinue corticosteroid until it does. If extensive areas are treated or if the occlusive technique is used, there will be increased systemic absorption of the corticosteroid, and suitable precautions, particularly with children and infants, should be taken. Long-term animal studies of topical corticosteroids have not been performed to evaluate their carcinogenic potential or their possible effect on fertility. Studies to determine mutagenicity with hydrocortisone have shown negative results. Safe use in pregnancy has not been established. Therefore, topical corticosteroids should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Do not use extensively,

First Page Preview View Large
First page PDF preview
First page PDF preview
×